Core Scientific, Inc.
CORZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,594 | $1,307 | $1,172 | $713 |
| - Cash | $836 | $50 | $52 | $132 |
| + Debt | $1,200 | $866 | $38 | $819 |
| Enterprise Value | $3,958 | $2,122 | $1,157 | $1,400 |
| Revenue | $511 | $502 | $640 | $544 |
| % Growth | 1.6% | -21.5% | 17.6% | – |
| Gross Profit | $121 | $123 | $8 | $239 |
| % Margin | 23.7% | 24.6% | 1.3% | 43.9% |
| EBITDA | -$1,157 | -$63 | -$1,840 | $141 |
| % Margin | -226.6% | -12.6% | -287.4% | 25.9% |
| Net Income | -$1,315 | -$246 | -$2,146 | $47 |
| % Margin | -257.5% | -49.1% | -335.2% | 8.7% |
| EPS Diluted | -5.14 | -0.65 | -6.3 | 0.2 |
| % Growth | -690.8% | 89.7% | -3,250% | – |
| Operating Cash Flow | $43 | $65 | $205 | -$57 |
| Capital Expenditures | -$95 | -$16 | -$602 | -$59 |
| Free Cash Flow | -$52 | $49 | -$396 | -$116 |